On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition.

Liu X, Liang S, Sang X, Chang L, Fu S, Yang H, Yang H, Liu Y, Zhang N

Open source

DOI
10.1016/j.apsb.2022.09.004
Published
2023 Apr
Container
Acta pharmaceutica Sinica. B
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2022.09.004,
  title = {On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition.},
  author = {Liu X and Liang S and Sang X and Chang L and Fu S and Yang H and Yang H and Liu Y and Zhang N},
  year = {2023},
  journal = {Acta pharmaceutica Sinica. B},
  doi = {10.1016/j.apsb.2022.09.004},
  url = {https://doi.org/10.1016/j.apsb.2022.09.004}
}

RIS

TY  - JOUR
TI  - On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition.
AU  - Liu X
AU  - Liang S
AU  - Sang X
AU  - Chang L
AU  - Fu S
AU  - Yang H
AU  - Yang H
AU  - Liu Y
AU  - Zhang N
PY  - 2023
JO  - Acta pharmaceutica Sinica. B
DO  - 10.1016/j.apsb.2022.09.004
UR  - https://doi.org/10.1016/j.apsb.2022.09.004
ER  -

APA

X, L., S, L., X, S., L, C., S, F., H, Y., H, Y., Y, L., & N, Z. (2023). On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2022.09.004

Source records